338 related articles for article (PubMed ID: 28861319)
1. Steroid hormone receptors as prognostic markers in breast cancer.
Louie MC; Sevigny MB
Am J Cancer Res; 2017; 7(8):1617-1636. PubMed ID: 28861319
[TBL] [Abstract][Full Text] [Related]
2. Steroid hormone receptor expression in male breast cancer.
Murphy CE; Carder PJ; Lansdown MR; Speirs V
Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
4. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
5. Sex steroid receptors in rheumatoid arthritis.
Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H
Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589
[TBL] [Abstract][Full Text] [Related]
6. The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients.
Esfahlan RJ; Zarghami N; Esfahlan AJ; Mollazadeh M; Nejati K; Nasiri M
Breast Cancer (Auckl); 2011; 5():227-37. PubMed ID: 22174584
[TBL] [Abstract][Full Text] [Related]
7. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
8. The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR.
Pfaffl MW; Lange IG; Meyer HH
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):159-66. PubMed ID: 12710999
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Mafuvadze B; Liang Y; Hyder SM
Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
[TBL] [Abstract][Full Text] [Related]
11. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
12. Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.
Barrios-García T; Gómez-Romero V; Tecalco-Cruz Á; Valadéz-Graham V; León-Del-Río A
Mol Genet Metab Rep; 2016 Jun; 7():20-6. PubMed ID: 27114912
[TBL] [Abstract][Full Text] [Related]
13. Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.
Jönsson JM; Arildsen NS; Malander S; Måsbäck A; Hartman L; Nilbert M; Hedenfalk I
Transl Oncol; 2015 Oct; 8(5):424-433. PubMed ID: 26500033
[TBL] [Abstract][Full Text] [Related]
14. Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy.
Schrijver WAME; Schuurman K; van Rossum A; ; Peeters T; Ter Hoeve N; Zwart W; van Diest PJ; Moelans CB
Oncotarget; 2017 Aug; 8(33):55550-55561. PubMed ID: 28903441
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptors in breast cancer: more than estrogen receptors.
Lamb CA; Vanzulli SI; Lanari C
Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
[TBL] [Abstract][Full Text] [Related]
16. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor action: defining a role in breast cancer.
Daniel AR; Hagan CR; Lange CA
Expert Rev Endocrinol Metab; 2011 May; 6(3):359-369. PubMed ID: 21857868
[TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast cancer: role of the androgen receptor.
Gucalp A; Traina TA
Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer.
Schüler-Toprak S; Weber F; Skrzypczak M; Ortmann O; Treeck O
BMC Cancer; 2018 Oct; 18(1):981. PubMed ID: 30326857
[TBL] [Abstract][Full Text] [Related]
20. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
